251 related articles for article (PubMed ID: 20479693)
1. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
Siva S; MacManus M; Ball D
J Thorac Oncol; 2010 Jul; 5(7):1091-9. PubMed ID: 20479693
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of single dose stereotactic radiotherapy for lung metastases.
Osti MF; Carnevale A; Valeriani M; De Sanctis V; Minniti G; Cortesi E; Martelli M; Maurizi Enrici R
Clin Lung Cancer; 2013 Nov; 14(6):699-703. PubMed ID: 23886798
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Ahmed KA; Torres-Roca JF
Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiotherapy for Lung Oligo-metastases: Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines.
Mayinger M; Kotecha R; Sahgal A; Kim MS; Lo SS; Louie AV; Scorsetti M; Slotman B; Guckenberger M
Lung Cancer; 2023 Aug; 182():107284. PubMed ID: 37390723
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis.
Jingu K; Matsushita H; Yamamoto T; Umezawa R; Ishikawa Y; Takahashi N; Katagiri Y; Takeda K; Kadoya N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794936. PubMed ID: 30145943
[TBL] [Abstract][Full Text] [Related]
7. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
8. Oligometastases: history of a hypothesis.
Milano MT; Biswas T; Simone CB; Lo SS
Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.
Takeda A; Sanuki N; Tsurugai Y; Oku Y; Aoki Y
J Radiat Res; 2016 Jul; 57(4):400-5. PubMed ID: 26983981
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiotherapy Results for Pulmonary Oligometastases: A Two-Institution Collaborative Investigation.
Niibe Y; Yamashita H; Sekiguchi K; Takahashi W; Shiraishi K; Okuma K; Terahara A; Kawamori J; Nakagawa K
Anticancer Res; 2015 Sep; 35(9):4903-8. PubMed ID: 26254386
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease.
Bhattacharya IS; Woolf DK; Hughes RJ; Shah N; Harrison M; Ostler PJ; Hoskin PJ
Br J Radiol; 2015 Apr; 88(1048):20140712. PubMed ID: 25679321
[TBL] [Abstract][Full Text] [Related]
18. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.
Siva S; Pham D; Gill S; Corcoran NM; Foroudi F
BJU Int; 2012 Dec; 110(11 Pt B):E737-43. PubMed ID: 23107102
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy for oligometastatic lung tumors.
Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
